Insanitary Storage Of FDA-Regulated Products Costs Family Dollar Nearly 42 Million Dollars

Nearly 1,300 rodents exterminated at Arkansas warehouse after FDA investigation found lack of climate control in store of food and OTC drugs requiring dry, room-temperature conditions. Firm pleads guilty in largest monetary criminal penalty in US food safety case.

• Source: Shutterstock

A Food and Drug Administration inspection of a Dollar Tree Inc. subsidiary’s warehouse in Arkansas led to the extermination of nearly 1,300 rodents there and charges costing the firm a lot of dollars, the largest monetary criminal penalty in a US food safety case.

More from Compliance

Traceability Rule Compliance Extended For Providers Of Herbals, Other Food Ingredients

 

FDA says “extension affords covered entities the additional time necessary to ensure complete coordination across the supply chain in order to fully implement the final rule’s requirements—ultimately providing FDA and consumers with greater transparency and food safety.”

PAGB Launches E-Learning Platform Including CBD ‘Deep Dive’

 
• By 

UK industry association is offering online courses on subjects ranging from UK medicines regulations basics to deep dives on complex topics such as CBD.

CRN Urges Tighter NDI Enforcement, Offers Its OWL As Model For FDA’s Potential Mandatory List

 

Trade group ready to work hand-in-hand with agency and other supplement industry stakeholders on potential regulatory changes or improvements, says president and CEO Steve Mister. “None of them are upsetting the basic balance of things that DSHEA was attempting to do, but there are things with 30 years that we've identified that need to be kind of fixed.”

Age-Restricting Sales Of Supplements, OTCs Remains Action Item For New Jersey Lawmakers

 

New Jersey Assembly passed bill amended to expand extensively in defining which products, or ingredients, would be subject to a ban on sales to consumers younger than 18.

More from Policy & Regulation

Over The Counter: What To Expect From The 61st AESGP Annual Meeting, With Jurate Švarcaite

 
• By 

HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.

US Supplement Industry Needs Relief From ‘Drug Preclusion’ Policy, CRN Reminds FDA

 

CRN petition argues against general preclusion while NPA petition addressed specifically FDA’s wielding of the provision to prohibit the use of NMN supplements available in US. “FDA has acknowledged that they really can't answer one without answering. The two are inextricably linked,” says CRN CEO Steve Mister.

HHS Secretary Kennedy Directs FDA To Consider Axing Self-Affirmed GRAS ‘Loophole’

 

Eliminating self-affirmation process would require companies to publicly notify FDA of their intended use of ingredients and provide safety data before they’re introduced. Kennedy says the process is “a loophole” for introducing ingredients and chemicals “with unknown safety data.”